Deep Genomics discovers therapeutic candidate through its AI platform
10 October 2019
Deep Genomics, a company specialising in AI therapeutics, has announced that its artificial intelligence-based drug discovery platform has identified a novel treatment target and corresponding drug candidate for Wilson disease
